Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2010-11-01

Clinical Trial Update: A Study of Leuprolide to Treat Prostate Cancer [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating leuprolide for prostate cancer has completed, with results posted in November 2010.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Leuprolide (Leuprolide acetate)

Snippet

Sponsor: Abbott | Conditions: Prostate Cancer | Phase 3 | Status: COMPLETED | Results posted: 2010-11-01